| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -12% |
| 3Y CAGR | 0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -58% |
| 3Y CAGR | -10% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,671.00 -13.40 (0.29%) | 21,441.05 | 29.16 | 5.1 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,704.50 +187.10 (7.43%) | 19,134.04 | 28.22 | 5.34 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,948.50 -3.00 (0.04%) | 17,426.88 | 102.74 | 19.97 | ||
Natco PharmaNATCOPHARM | ₹844.95 +3.45 (0.41%) | 15,085.53 | 13.18 | 1.64 |